ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,000 | +57.1% | 247 | +1.6% | 0.00% | – |
| Q3 2021 | $14,000 | +1300.0% | 243 | +2109.1% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -75.0% | 11 | -82.5% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 63 | -3.1% | 0.00% | – |
| Q1 2020 | $3,000 | -76.9% | 65 | -79.6% | 0.00% | – |
| Q4 2019 | $13,000 | -99.1% | 318 | -99.0% | 0.00% | -100.0% |
| Q3 2019 | $1,523,000 | +50666.7% | 33,257 | +41997.5% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 79 | +58.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 50 | -5.7% | 0.00% | – |
| Q3 2018 | $2,000 | -80.0% | 53 | -76.7% | 0.00% | – |
| Q2 2018 | $10,000 | -97.5% | 227 | -97.7% | 0.00% | – |
| Q1 2018 | $393,000 | +4.5% | 9,956 | -10.0% | 0.00% | – |
| Q4 2017 | $376,000 | -41.0% | 11,060 | -55.7% | 0.00% | -100.0% |
| Q3 2017 | $637,000 | +15825.0% | 24,944 | +12372.0% | 0.00% | – |
| Q2 2017 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |